Integrated Core Strategies (US) LLC 13D and 13G filings for Milestone Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-29 4:30 pm Purchase | 2024-09-30 | 13G | Milestone Pharmaceuticals Inc. MIST | Integrated Core Strategies (US) LLC | 2,778,525 5.200% | 1,047,636 (+60.53%) | Filing |
| 2024-01-29 4:42 pm Sale | 2023-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | Integrated Core Strategies (US) LLC | 1,730,889 5.200% | -464,140 (-21.15%) | Filing |
| 2023-01-18 4:40 pm Purchase | 2022-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | Integrated Core Strategies (US) LLC | 2,195,029 6.400% | 290,732 (+15.27%) | Filing |
| 2022-10-31 4:40 pm Purchase | 2022-10-25 | 13G | Milestone Pharmaceuticals Inc. MIST | Integrated Core Strategies (US) LLC | 1,904,297 6.300% | 1,904,297 (New Position) | Filing |